Israel has been held up as the “gold standard” of how to conduct the coronavirus vaccine rollout. It has seen approximately 70% of its population receive the jab. The Israelis have relied in the main on the Pfizer vaccine. However, recently the country’s Prime Minister, Naftali Bennett, stated that the Pfizer vaccine is ‘significantly less’ effective against the so-called Delta variant. This follows on from a statement last June by Ran Balicer, who leads an expert advisory panel for the Israeli government, in announcing that the country might end up in lockdown again.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in